Crude Oil Drops 1%; General Motors Earnings Miss Views
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 200 points on Tuesday.
Dow Drops Over 100 Points; Coca-Cola Tops Q2 Views
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Tuesday.
Dow Rises Over 100 Points; Revelation Biosciences Shares Spike Higher
U.S. stocks traded mostly higher midway through trading on Monday.
Why U.S. Stocks Are Trading Mostly Higher; Chicago Fed National Activity Index Remains Unchanged
U.S. stocks traded mostly higher this morning, with the Dow Jones gaining around 100 points on Monday.
Novartis’ Sandoz Unit Announced Applications for Proposed First-of-a-kind Multiple Sclerosis Biosimilar Natalizumab Accepted by US FDA and EMA
Sandoz, a global leader in generic and biosimilar medicines, announced today that the US Food and Drug Administration (FDA) has accepted its biologics license application (BLA) for a proposed first-of-a-kind biosimilar natalizumab, developed by Polpharma Biologics.
AstraZeneca Announced Ultomiris Recommended for Approval in the EU by CHMP for the Treatment of Adults with Generalized Myasthenia Gravis
Ultomiris (ravulizumab) has been recommended for marketing authorisation in the European Union (EU) as an add-on to standard therapy for the treatment of adult patients with generalised myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody-positive.
AstraZeneca Announced Tezspire Recommended for EU Approval in Asthma
AstraZeneca's Tezspire (tezepelumab) has been recommended for marketing authorisation in the European Union (EU) as an add-on therapy in patients 12 years and older with severe asthma who are inadequately controlled with high dose inhaled corticosteroids plus another medicinal product for maintenance treatment.
Dow Dips More Than 200 Points; Crude Oil Moves Lower
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 200 points on Friday.